Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal Chawla

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Future Oncology (London, England)|April 26, 2021
Evolving role of entrectinib in treatment of <i>NTRK</i>-positive tumorsNeal Chawla, Nam Q Bui, Mahesh Seetharam
Advances in Therapy|May 29, 2016
Trabectedin for Soft Tissue Sarcoma: Current Status and Future PerspectivesErlinda M Gordon, K Kumar Sankhala, Neal Chawla, et al.
Advances in Cancer Research|June 29, 2020
MET receptor in oncology: From biomarker to therapeutic targetRaeva Malik, Isa Mambetsariev, Jeremy Fricke, et al.
Joint Commission Journal on Quality and Patient Safety|April 21, 2010
Clinical information system and process redesign improves emergency department efficiencyKevin M Baumlin, Jason S Shapiro, Corey Weiner, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|June 12, 2010
Emergency department information system implementation and process redesign result in rapid and sustained financial enhancement at a large academic centerJason S Shapiro, Kevin M Baumlin, Neal Chawla, et al.
Frontiers in Immunology|August 28, 2023
Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profilesAmeish Govindarajan, Nicholas J Salgia, Haiqing Li, et al.
JCO Precision Oncology|April 7, 2023
Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell CarcinomaAlexander Chehrazi-Raffle, Ramya Muddasani, Nazli Dizman, et al.
The Oncologist|July 11, 2023
Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell CarcinomaAlexander Chehrazi-Raffle, Sally Leong, Sana Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2021
Complementary Role of Circulating Tumor DNA Assessment and Tissue Genomic Profiling in Metastatic Renal Cell CarcinomaZeynep B Zengin, Caroline Weipert, Nicholas J Salgia, et al.
Annals of Emergency Medicine|September 1, 2009
Forecasting emergency department crowding: an external, multicenter evaluationNathan R Hoot, Stephen K Epstein, Todd L Allen, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Future Oncology (London, England)|April 26, 2021
Evolving role of entrectinib in treatment of <i>NTRK</i>-positive tumorsNeal Chawla, Nam Q Bui, Mahesh Seetharam
Advances in Therapy|May 29, 2016
Trabectedin for Soft Tissue Sarcoma: Current Status and Future PerspectivesErlinda M Gordon, K Kumar Sankhala, Neal Chawla, et al.
Advances in Cancer Research|June 29, 2020
MET receptor in oncology: From biomarker to therapeutic targetRaeva Malik, Isa Mambetsariev, Jeremy Fricke, et al.
Joint Commission Journal on Quality and Patient Safety|April 21, 2010
Clinical information system and process redesign improves emergency department efficiencyKevin M Baumlin, Jason S Shapiro, Corey Weiner, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|June 12, 2010
Emergency department information system implementation and process redesign result in rapid and sustained financial enhancement at a large academic centerJason S Shapiro, Kevin M Baumlin, Neal Chawla, et al.
Frontiers in Immunology|August 28, 2023
Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profilesAmeish Govindarajan, Nicholas J Salgia, Haiqing Li, et al.
JCO Precision Oncology|April 7, 2023
Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell CarcinomaAlexander Chehrazi-Raffle, Ramya Muddasani, Nazli Dizman, et al.
The Oncologist|July 11, 2023
Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell CarcinomaAlexander Chehrazi-Raffle, Sally Leong, Sana Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2021
Complementary Role of Circulating Tumor DNA Assessment and Tissue Genomic Profiling in Metastatic Renal Cell CarcinomaZeynep B Zengin, Caroline Weipert, Nicholas J Salgia, et al.
Annals of Emergency Medicine|September 1, 2009
Forecasting emergency department crowding: an external, multicenter evaluationNathan R Hoot, Stephen K Epstein, Todd L Allen, et al.
Pageof 2